BioCardia (BCDA) Operating Leases (2019 - 2026)

BioCardia (BCDA) has reported Operating Leases for 8 consecutive years, with $293000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Operating Leases fell 60.67% year-over-year to $293000.0 in Q2 2026; TTM through Jun 2026 was $293000.0, a 60.67% decrease from a year earlier, with the FY2025 full-year figure at $86000.0, down 84.81% from the prior year.
• Operating Leases was $293000.0 for Q2 2026 at BioCardia, down from $412000.0 in the prior quarter.
• Over five years, Operating Leases peaked at $1.8 million in Q1 2022 and troughed at $86000.0 in Q4 2025.
• A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Operating Leases.
• Across the five-year window, Operating Leases surged 292.95% in 2022 and sank 84.81% in 2025, its largest moves.
• Over 5 years, Operating Leases stood at $1.3 million in 2022, then fell by 25.38% to $982000.0 in 2023, then sank by 42.36% to $566000.0 in 2024, then slumped by 84.81% to $86000.0 in 2025, then soared by 240.7% to $293000.0 in 2026.
• The last three Operating Leases figures came in at $293000.0 (Q2 2026), $412000.0 (Q1 2026), and $86000.0 (Q4 2025), per Business Quant data.